In our case, the concomitant loss of MSH2 and MSH6 proteins expression in both endometrioid and intestinal tumor components provided indirect evidence of a shared molecular alteration and a very-likely clonal origin from a common neoplastic progenitor. The gene discussed is MSH2; the disease is intestinal neoplasm.